October 25, 2021
Hims & Hers Health has had its biggest one-day loss in over two months, following its rival 23andMe’s agreement to buy web-based healthcare platform Lemonaid Health. Hims & Hers is a telehealth platform working on custom health and wellness in multi-specialty needs. The report from Seeking Alpha says although there’s a buy rating on 23andMe, […]
